Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Disease Burden and Etiologic Distribution of Community-Acquired Pneumonia in Adults: Evolving Epidemiology in the Era of Pneumococcal Conjugate Vaccines

Full metadata record
DC Field Value Language
dc.contributor.authorHeo, Jung Yeon-
dc.contributor.authorSong, Joon Young-
dc.date.accessioned2021-09-02T02:42:26Z-
dc.date.available2021-09-02T02:42:26Z-
dc.date.created2021-06-18-
dc.date.issued2018-12-
dc.identifier.issn2093-2340-
dc.identifier.urihttps://scholar.korea.ac.kr/handle/2021.sw.korea/71475-
dc.description.abstractPneumonia is the leading cause of morbidity and mortality, particularly in old adults. The incidence and etiologic distribution of community-acquired pneumonia is variable both geographically and temporally, and epidemiology might evolve with the change of population characteristics and vaccine uptake rates. With the increasing prevalence of chronic medical conditions, a wide spectrum of healthcare-associated pneumonia could also affect the epidemiology of community-acquired pneumonia. Here, we provide an overview of the epidemiological changes associated with community-acquired pneumonia over the decades since pneumococcal conjugate vaccine introduction.-
dc.languageEnglish-
dc.language.isoen-
dc.publisherKOREAN SOC CHEMOTHERAPY-
dc.subjectCARE-ASSOCIATED PNEUMONIA-
dc.subjectCLINICAL-OUTCOMES-
dc.subjectHOSPITALIZED-PATIENTS-
dc.subjectRESISTANT PATHOGENS-
dc.subjectANTIBIOTIC-THERAPY-
dc.subjectHERD PROTECTION-
dc.subjectECONOMIC BURDEN-
dc.subjectPOPULATION-
dc.subjectGUIDELINE-
dc.subjectADMISSIONS-
dc.titleDisease Burden and Etiologic Distribution of Community-Acquired Pneumonia in Adults: Evolving Epidemiology in the Era of Pneumococcal Conjugate Vaccines-
dc.typeArticle-
dc.contributor.affiliatedAuthorSong, Joon Young-
dc.identifier.doi10.3947/ic.2018.50.4.287-
dc.identifier.scopusid2-s2.0-85059535469-
dc.identifier.wosid000454653900001-
dc.identifier.bibliographicCitationINFECTION AND CHEMOTHERAPY, v.50, no.4, pp.287 - 300-
dc.relation.isPartOfINFECTION AND CHEMOTHERAPY-
dc.citation.titleINFECTION AND CHEMOTHERAPY-
dc.citation.volume50-
dc.citation.number4-
dc.citation.startPage287-
dc.citation.endPage300-
dc.type.rimsART-
dc.type.docTypeReview-
dc.identifier.kciidART002423743-
dc.description.journalClass1-
dc.description.journalRegisteredClassscopus-
dc.description.journalRegisteredClasskci-
dc.relation.journalResearchAreaInfectious Diseases-
dc.relation.journalWebOfScienceCategoryInfectious Diseases-
dc.subject.keywordPlusCARE-ASSOCIATED PNEUMONIA-
dc.subject.keywordPlusCLINICAL-OUTCOMES-
dc.subject.keywordPlusHOSPITALIZED-PATIENTS-
dc.subject.keywordPlusRESISTANT PATHOGENS-
dc.subject.keywordPlusANTIBIOTIC-THERAPY-
dc.subject.keywordPlusHERD PROTECTION-
dc.subject.keywordPlusECONOMIC BURDEN-
dc.subject.keywordPlusPOPULATION-
dc.subject.keywordPlusGUIDELINE-
dc.subject.keywordPlusADMISSIONS-
dc.subject.keywordAuthorPneumonia-
dc.subject.keywordAuthorIncidence-
dc.subject.keywordAuthorMortality-
dc.subject.keywordAuthorEpidemiology-
dc.subject.keywordAuthorPneumococcal conjugate vaccine-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE